Information Provided By:
Fly News Breaks for February 14, 2019
CDXC
Feb 14, 2019 | 04:47 EDT
B. Riley FBR analyst Jeff Van Sinderen started ChromaDex with a Buy rating and $7 price target. The analyst says the company's bioscience-based products support better aging and enhanced performance.
News For CDXC From the Last 2 Days
There are no results for your query CDXC